Educational Programmes

Skin toxicity related to targeted therapy
Internationally accredited e-learning on skin toxicity related to targeted therapy in liver and GI cancer
read more
HCC CONNECT e-learning with important new data on treatment sequencing in advanced HCC
HCC CONNECT eLearning with important new data on treatment sequencing in advanced HCC
read more







Updates on policies for liver transplantation
Dr. Neil Mehta discusses the recent updates on policies for liver transplantation in patients with hepatocellular carcinoma (HCC).
read more







HCC CONNECT review paper published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Five HCC CONNECT members authored the review paper ‘A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk’. The paper is published in Mayo Clinic Proceedings: Innovations, Quality & Outcomes and can be viewed here. Download the slides below for a summary.
read more







HCC CONNECT review paper published in Liver Cancer
Five HCC CONNECT members authored the review paper ‘Systemic treatment for advanced hepatocellular carcinoma’. The paper is published in Liver Cancer and can be viewed here. Download the slides below for a summary
read more







Understanding the changing treatment landscape in HCC
Dr. Richard Finn, Dr. Amit Singal and Dr. Catherine Frenette discuss the topic ‘Understanding the changing treatment landscape in HCC and optimising therapy for the individual patient’. Please click on the link to watch the video and download the slides.
read more







Update of EASL guidelines on management of HCC 2018
Dr. Catherine Frenette discusses the recently updated EASL clinical practice guidelines on the management of hepatocellular carcinoma (HCC).
read more







HCC highlights from EASL 2017
Dr. Catherine Frenette discusses the recently updated EASL clinical practice guidelines on the management of hepatocellular carcinoma (HCC).
read more










HCC CONNECT Update from ILCA and ESMO 2020
HCC CONNECT has summarised the highlights from ILCA and ESMO 2020 for you
read more










HCC CONNECT Update from WCGIC 2020
Dr. Mohamed Bouattour, Beaujon University Hospital, Clichy, Paris, provides and review of the liver oncology.
read more










HCC CONNECT Update from ASCO 2020
HCC CONNECT has summarised the highlights from ASCO 2020 for you.
read more










HCC CONNECT Update from AASLD 2019
HCC CONNECT has summarised the highlights from AASLD 2019
read more










HCC CONNECT Update from ESMO 2019
HCC CONNECT has summarised highlights of the recent ESMO 2019 meeting for you.
read more










HCC CONNECT Update from ASCO 2019
HCC CONNECT has summarised the highlights from ASCO 2019 for you
read more










HCC CONNECT has summarised the highlights from AASLD 2018 for you.
HCC CONNECT has summarised the highlights from ASCO 2019 for you
read more










HCC CONNECT Update from ILCA 2018
HCC CONNECT has summarised the highlights of ILCA 2018
read more










HCC CONNECT Update from ESMO 2018
HCC CONNECT has summarised the highlights from ESMO 2018 for you
read more










HCC CONNECT Update from Seoul and Washington DC
HCC CONNECT has summarised the highlights of ILCA 2017 and AASLD 2017.
read morePlease submit your clinical topic for the next HCC CONNECT newsletter here.









Targeted therapy approaches for cholangiocarcinoma
Dr. Roniel Cabrera discusses cholangiocarcinoma and targeted treatment approaches.
read more








Surveillance and novel risk factors for HCC
Dr. Walid Ayoub discusses recent data on surveillance and novel risk factors for hepatocellular carcinoma (HCC).
read more








Insights into trial designs in advanced HCC
Dr. Leonardo da Fonseca provides insights into trial designs in advanced hepatocellular carcinoma (HCC).
read more








Advances in risk factors for HCC
Dr. Sammy Saab looks at the advances in risk factors for HCC.
read more








Is there a difference in liver cancer rates in patients who receive treatment for hepatitis?
Dr. Sammy Saab discusses the clinical question: Is there a difference in liver cancer rates in patients who receive treatment for hepatitits?
read more








Sequencing of HCC treatment
Dr. Amit Singal discusses recent data on Sequencing of HCC Treatment.
read more








What is the best approach for trans-arterial therapy in HCC?
Dr. Alexander Kim discusses the clinical question: What is the best approach for trans-arterial therapy in HCC?
read more








HCC screening for early diagnosis: feasibility and reality?
Dr. Catherine Frenette discusses the Clinical Question: HCC screening for early diagnosis: feasibility and reality?
read more